Evidence map›Paper›PMID 26390156›Full record

ArticleNature immunology2015

K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8(+) T cell activation.

Mingjin Yang, Taoyong Chen, Xuelian Li, Zhou Yu, Songqing Tang, Chen Wang, Yan Gu, Yanfang Liu, Sheng Xu, Weihua Li and 3 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Ubiquitination in cancer: mechanisms and therapeutic opportunities.Cancer communications (London, England) · 2025
    Review
  9. Article
  10. STS2 deficiency revives CD8Journal for immunotherapy of cancer · 2025
    Article
  11. Review
  12. Article
  13. Gene Expression Dysregulation in Whole Blood of Patients withInternational journal of molecular sciences · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Ubiquitination of Immune System and Cancer Therapy.Advances in experimental medicine and biology · 2024
    Review
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Mingjin YangNational Key Laboratory of Medical Molecular Biology &Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China.
Taoyong ChenNational Key Laboratory of Medical Immunology &Institute of Immunology, Second Military Medical University, Shanghai, China.
Xuelian LiNational Key Laboratory of Medical Immunology &Institute of Immunology, Second Military Medical University, Shanghai, China.
Zhou YuInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
Songqing TangInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
Chen WangNational Key Laboratory of Medical Immunology &Institute of Immunology, Second Military Medical University, Shanghai, China.
Yan GuNational Key Laboratory of Medical Immunology &Institute of Immunology, Second Military Medical University, Shanghai, China.
Yanfang LiuNational Key Laboratory of Medical Immunology &Institute of Immunology, Second Military Medical University, Shanghai, China.
Sheng XuNational Key Laboratory of Medical Immunology &Institute of Immunology, Second Military Medical University, Shanghai, China.
Weihua LiInstitute of Basic Medical Sciences, National Center of Biomedical Analysis, Beijing, China.
Xuemin ZhangInstitute of Basic Medical Sciences, National Center of Biomedical Analysis, Beijing, China.
Jianli WangInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
Xuetao CaoNational Key Laboratory of Medical Molecular Biology &Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China.
Second Military Medical University · CNZhejiang University · CNNational Center of Biomedical Analysis · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The key molecular mechanisms that control signaling via T cell antigen receptors (TCRs) remain to be fully elucidated. Here we found that Nrdp1, a ring finger-type E3 ligase, mediated Lys33 (K33)-linked polyubiquitination of the signaling kinase Zap70 and promoted the dephosphorylation of Zap70 by the acidic phosphatase-like proteins Sts1 and Sts2 and thereby terminated early TCR signaling in CD8(+) T cells. Nrdp1 deficiency significantly promoted the activation of naive CD8(+) T cells but not that of naive CD4(+) T cells after engagement of the TCR. Nrdp1 interacted with Zap70 and with Sts1 and Sts2 and connected K33 linkage of Zap70 to Sts1- and Sts2-mediated dephosphorylation. Our study suggests that Nrdp1 terminates early TCR signaling by inactivating Zap70 and provides new mechanistic insights into the non-proteolytic regulation of TCR signaling by E3 ligases.

Indexed as

AnimalsCarrier ProteinsCD8-Positive T-LymphocytesLymphocyte ActivationLysineMice, CongenicMice, Inbred C57BLMice, KnockoutMicroscopy, ConfocalPhosphorylationPolyubiquitinProtein BindingReceptors, Antigen, T-CellReverse Transcriptase Polymerase Chain ReactionRNA InterferenceSignal TransductionCarrier ProteinsLysinePolyubiquitinReceptors, Antigen, T-CellRnf41 protein, mouseUbiquitin-Protein LigasesZap70 protein, mouseZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID26390156
OpenAlexW1812905037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.